Alopecia areata: vizsgálatok itt: Kína
9 trials · From ClinicalTrials.gov, checked 2026. november 15.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleA Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
- Where
- Beijing, Shanghai, Tianjin
- Életkor
- 18 év to 60 év
- People
- 65 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07533006 · EU 2025-524727-41-00 - 3. fázisTaking peopleA Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
- Where
- Beijing, Shanghai
- Életkor
- 12 év and over
- People
- 336 worldwide
- Run by
- Pfizer
See details and how to joinNCT07733765 - 3. fázisTaking peopleA Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
- Where
- Beijing, Changsha, Chengdu, Chongqing, Guangzhou, Hangzhou, Kunming, Nanchang, Nanjing, Shanghai
- Életkor
- 12 év and over
- People
- 674 worldwide
- Run by
- Pfizer
See details and how to joinNCT06873945 · EU 2024-519370-40-00 - 1. fázisTaking peopleA Phase I Study of VC005 Tablets in Adolescent Subjects With Severe Alopecia Areata
- Where
- Beijing
- Életkor
- 12 év to 18 év
- People
- 24
- Run by
- Jiangsu vcare pharmaceutical technology co., LTD
See details and how to joinNCT07762443 - 3. fázisTaking peopleA Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
- Where
- Beijing, Changchun, Chengdu, Chongqing, Guangzhou, Hangzhou, Jinan, Nanchang, Shanghai, Shenzhen, Taiyuan, Tianjin, Wenzhou, Wuhan, Xi'an
- Életkor
- 12 év to 63 év
- People
- 1500 worldwide
- Run by
- AbbVie
See details and how to joinNCT06012240 · EU 2023-505061-82-01 - 3. fázisTaking peopleA Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
- Where
- Beijing, Changsha, Chengdu, Guangzhou, Hangzhou, Shanghai
- Életkor
- 6 év to 14 év
- People
- 140 worldwide
- Run by
- Pfizer
See details and how to joinNCT07029828 · EU 2024-515439-31-00 - 2. fázisTaking peoplePhase II Clinical Study of VC005 Tablets in Subjects With Severe Alopecia Areata
- Where
- Beijing
- Életkor
- 18 év to 65 év
- People
- 120
- Run by
- Jiangsu vcare pharmaceutical technology co., LTD
See details and how to joinNCT07749716 - 1. fázisTaking peopleStudy to Evaluate the Safety, Tolerability and How IBI3013 is Taken up and Processed by the Body in Healthy Volunteers After Single-dose Administration, and in Non-segmental Vitiligo Patients and Alopecia Areata Patients After Multiple-dose Administration
- Where
- Shanghai
- Életkor
- 18 év to 80 év
- People
- 160
- Run by
- Innovent Biologics (Suzhou) Co. Ltd.
See details and how to joinNCT07554222 - No phaseTaking peopleEfficacy and Safety of JAK Inhibitors in Patients With AA: RWE Study
- Where
- Hangzhou
- Életkor
- 2 év to 80 év
- People
- 150
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06573593